Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cognitive and affective dysfunction in MS]

G Bergendal1, O Almkvist, S Fredrikson

  • 1MS-centrum, sektionen för neurologi, Karolinska Institutet och Neurologiska kliniken, Huddinge.

Nordisk Medicin
|January 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epilepsy in second-generation immigrants: a cohort study of all children up to 18 years of age in Sweden.

European journal of neurology·2019
Same author

Gadolinium Retention in the Brain: An MRI Relaxometry Study of Linear and Macrocyclic Gadolinium-Based Contrast Agents in Multiple Sclerosis.

AJNR. American journal of neuroradiology·2019
Same author

Detection of Leukocortical Lesions in Multiple Sclerosis and Their Association with Physical and Cognitive Impairment: A Comparison of Conventional and Synthetic Phase-Sensitive Inversion Recovery MRI.

AJNR. American journal of neuroradiology·2018
Same author

Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general management.

European journal of neurology·2018
Same author

Decisions and attitudes regarding participation and proxy in clinical trials among patients with impaired cognitive function.

Dementia (London, England)·2017
Same author

Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.

Molecular psychiatry·2017
Same journal

[Nordisk Medicine 1929-1998. Thanks and farewell!].

Nordisk medicin·1999
Same journal

[Scientific fraud and misconduct--need for comprehensive terminology].

Nordisk medicin·1999
Same journal

[Labor-market for Scandinavian physicians in the year 2000--dearth or surplus?].

Nordisk medicin·1999
Same journal

[Internet in consultation--headed for trouble?].

Nordisk medicin·1999
Same journal

[Interpretation of questionnaires. An translation method problem].

Nordisk medicin·1999
Same journal

[Assessment of patients' health status--review of the literature and assessment methods].

Nordisk medicin·1999
See all related articles

Cognitive and affective disorders are common in multiple sclerosis (MS). Advanced SPECT imaging can reveal the brain systems involved, improving patient management.

Area of Science:

  • Neuroscience
  • Neurology
  • Medical Imaging

Context:

  • Multiple Sclerosis (MS) frequently presents with cognitive and affective disorders.
  • Understanding the underlying cerebral systems is crucial but limited.
  • Existing research lacks detailed insights into the brain's functional dynamics in MS-related disorders.

Purpose:

  • To explore the utility of functional imaging techniques, specifically sophisticated Single Photon Emission Computed Tomography (SPECT), in understanding cognitive and affective processes in MS.
  • To investigate the cerebral blood flow dynamics associated with these disorders.
  • To bridge the knowledge gap regarding the neural underpinnings of MS-related cognitive and affective impairments.

Summary:

  • Prevalence studies confirm high rates of cognitive and affective disorders in Multiple Sclerosis (MS).

Related Experiment Videos

  • Functional imaging, particularly advanced Single Photon Emission Computed Tomography (SPECT), offers a method to measure cerebral blood flow and visualize brain activity.
  • SPECT techniques can elucidate the dynamic cerebral processes involved in cognitive and affective functions within the MS population.

    • Impact:

    • Enhanced understanding of the cerebral systems affected by cognitive and affective disorders in MS.
    • Potential for improved diagnostic accuracy and personalized treatment strategies for MS patients.
    • Foundation for developing targeted rehabilitation programs to enhance patient outcomes and quality of life.